Fluidra
€17.50Change from previous close: +1.80%Absolute change: +€0.31
At a glance
- Revenue growth
- +3.96%
- 2025 vs 2024
- Net income growth
- +27.49%
- 2025 vs 2024
- Net margin
- 7.9%
- 2024: 6.5%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 214 | -133 | 144 | 208 | -177 |
| Depreciation and amortization | 40.0 | 38.9 | 42.5 | 38.9 | 40.7 |
| Capital expenditure | -17.7 | -17.3 | -25.4 | -13.8 | -14.2 |
| Investing cash flow | -11.1 | -28.4 | -84.7 | -47.6 | -32.4 |
| Financing cash flow | -129 | 103 | -81.2 | -101 | 120 |
| Dividends paid | — | — | -58.4 | -0.5 | -0.3 |
| Share repurchases | -36.7 | -26.5 | -24.8 | -29.6 | -25.8 |
| Debt issued | -113 | 118 | — | -85.9 | 137 |
| Debt repaid | -2.7 | -2.7 | -4.8 | -2.9 | -4.3 |
| Effect of exchange rates | 1.9 | 4.0 | 0.7 | -12.8 | -6.7 |
| Net change in cash | 73.8 | -58.9 | -22.3 | 59.4 | -89.1 |
| Free cash flow | 197 | -151 | 118 | 194 | -191 |